NCT05140200View on ClinicalTrials.gov

Study of GSK3511294 in Healthy Chinese Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

December 23, 2022

Study Completion Date

December 23, 2022

Conditions

Asthma

Interventions

BIOLOGICAL

GSK3511294

GSK3511294 will be administered.

Trial Locations (1)

310006

GSK Investigational Site, Hangzhou

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT05140200 - Study of GSK3511294 in Healthy Chinese Participants | Biotech Hunter | Biotech Hunter